|
?:authorAffiliation
|
-
[\'B.L. Bermas, MD, UTSouthwestern Medical Center, Dallas, Texas, USA.\', \'M. Gianfrancesco, MPH, PhD, A.M. Seet, MPH, J. Yazdany, MPH, MD, Division of Rheumatology, School of Medicine, University of California, San Francisco, California, USA.\', \'H.L. Tanner, MBChB, FRACP, University of Queensland School of Clinical Medicine, Faculty of Medicine, Queensland, Australia.\', \'M.C. Aguiar, MD, Hospital General Agustin O\'Horan, Merida, Mexico.\', \'N.K. Al Adhoubi, MD, FRCP, Rheumatology Unit, Royal Hospital, Muscat, Oman.\', \'S. Al Emadi, MBBS, FRCPC, Hamad Medical Corporation, Doha, Qatar.\', \'B.M. Cunha, MD, PhD, Sarah Network of Rehabilitation Hospitals, Brasília, Brazil.\', \'R. Flood, MB, BCh, BAO, Tallaght University Hospital, Tallaght, Dublin, Ireland.\', \'D.A. Kusevich, MD,PhD, V.A. Nasonova Research Institute of Rheumatology, Moscow, and Anikina Clinic, Vidnoe, Russia.\', \'E.M. McCarthy, MB, MRCPI, Manchester University Foundation Trust, Manchester, UK.\', \'N.J. Patel, MD, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'E.M. Ruderman, MD, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.\', \'S.E. Sattui, MD, MS, Hospital for Special Surgery, New York, New York, USA.\', \'S. Sciascia, MD, PhD, Center of Research of Immunopathology and Rare Diseases/Nephrology and Dialysis Unit, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, Turin, Italy.\', \'F. Siddique, MD, Loyola University Medical Center, Maywood, Illinois, USA.\', \'M.O. Valenzuela-Almada, MBBS, A. Duarte-Garcia, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.\', \'L.M. Wise, MD, University of Southern California, Los Angeles, California, USA.\', \'A.B. Worthing, MD, Arthritis & Rheumatism Associates, PC, and Georgetown University Medical Center, Washington, DC, USA.\', \'J. Zell, MD, University of Colorado, Aurora, Colorado, USA.\', \'S. Bhana, MD, Crystal Run Healthcare, Middletown, New York, USA.\', \'W. Costello, Irish Children\'s arthritis network (iCan), Tipperary, Ireland.\', \'R. Grainger, MBChB, PhD, FRACP, Department of Medicine, University of Otago, Wellington, New Zealand.\', \'L. Gossec, MD, PhD, Sorbonne Université, INSERM, Institut Pierre Louis d\'Epidémiologie et de Santé Publique, and Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Rheumatology Department, Paris, France.\', \'J.S. Hausmann, MD, Program in Rheumatology, Division of Immunology, Boston Children\'s Hospital, and Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.\', \'K. Hyrich, MD, PhD, FRCPC, Centre for Epidemiology Versus Arthritis, The University of Manchester, and National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.\', \'S. Lawson-Tovey, BA, National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, and Centre for Genetics and Genomics Versus Arthritis, The University of Manchester, Manchester, UK.\', \'J.W. Liew, MS, MD, Boston University School of Medicine, Boston, Massachusetts, USA.\', \'E. Sirotich, BSc, Department of Health Research, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.\', \'J.A. Sparks, MD, MMSc, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women\'s Hospital and Harvard Medical School, Boston, Massachusetts, USA.\', \'P. Sufka, MD, Healthpartners, St. Paul, Minnesota, USA.\', \'Z.S. Wallace, MD, MSc, Rheumatology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.\', \'P.M. Machado, MD, PhD, Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, and National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, and Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.\', \'A. Strangfeld, MD, Epidemiology Unit, German Rheumatism Research Centre (DRFZ) Berlin, Berlin, Germany.\', \'M.E.B. Clowse, MD, MPH, Duke University School of Medicine, Durham, North Carolina, USA.\', \'P.C. Robinson, MBChB, PhD, FRACP, Associate Professor, University of Queensland School of Clinical Medicine, Faculty of Medicine, Queensland, Australia, and Royal Brisbane & Women\'s Hospital, Metro North Hospital & Health Service, Herston, Queensland, Australia. philip.robinson@uq.edu.au.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}